drugset / Trial / NCT01410370
Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Phase 2
Unknown
80 enrolled
Jiangsu Simcere Pharmaceutical Co., Ltd.
The First People's Hospital of Lianyungang · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the clinical efficacy and safety of continuous Endostar infusion combined with radiotherapy for treatment of brain metastases.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 7.5 mg/m2 | — |